SBRA Sabra Health Care REIT (SBRA) Insider Trading, Ownership & Congress Trades
Real Estate · Real estate investment trusts · CIK 0001492298
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
232
13F, latest reported quarter
What the filings say about SBRA
Insiders, 180 days
-$4.2M net sold
1 seller · 100% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$4.2M
1 notice
Sabra Health Care REIT insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Sabra Health Care REIT, Inc. insiders sold a net $4.2M of stock across 10 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 12.1% of the 1,657,686 shares held after it.
- No other insider sold within 30 days.
- 232 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chair, CEO and President MATROS RICHARD K sold about $4.2M of SBRA under a 10b5-1 plan on Sep 8, 2026, the largest insider sale at the company on our record; 232 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 21.2% of the 71,709 shares held after it.
- No other insider sold within 30 days.
- 232 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive VP & CAO FLORES JESSICA sold about $302.5K of SBRA on Mar 25, 2026, the largest insider sale at the company since 2021; 232 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 14, 2024.
- The trade is 17.0% of the 64,725 shares held after it.
- No other insider sold within 30 days.
- 232 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director FOSTER MICHAEL J sold about $200.4K of SBRA on May 20, 2025, the largest insider sale at the company since 2021; 232 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Feb 21, 2025.
- +9.4% median (+10.4% mean) 90-day return after 3 previous buys.
- The trade is 2.5% of the 60,583 shares held after it.
- No other insider bought within 30 days.
- 232 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cusack Catherine bought about $23.9K of SBRA on Feb 24, 2025; 232 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on May 22, 2024.
- +10.9% median (+10.9% mean) 90-day return after 2 previous buys.
- The trade is 1.7% of the 59,083 shares held after it.
- No other insider bought within 30 days.
- 232 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Cusack Catherine bought about $16.4K of SBRA on Feb 21, 2025; 232 funds added in the latest 13F quarter.10 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$4.2M over 180 days
-$4.2M over 90 days
below 88% of Real Estate
Congress
no House purchase disclosed in the last 12 months
Funds
232 funds bought in last quarter
more than 78% of Real Estate
Revenue
+25.4% year over year
more than 86% of Real Estate
Margin
43.6% net margin
more than 80% of Real Estate
Buybacks
no share repurchases reported
Short interest
7.0% of the float short (float per yahoo 2026-10-27) · 7.2 days to cover · settled 2026-10-15
more than 75% of Real Estate
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch SBRA
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+15.4%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns SBRA: institutional holders (13F)
13F holdings, latest reported quarter
41,614,351 sh
$811.9M
24,706,070 sh
$482.0M
23,352,373 sh
$455.6M
12,305,655 sh
$240.1M
11,349,125 sh
$221.4M
Congress trades in SBRA
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
SBRA planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Richard K. Matros
Filed 2026-09-08
$4.2M
SBRA mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Principal Real Estate Active Opportunities ETF
$1.1M position · as of 2026-06-30
4.4%
Global X SuperDividend REIT ETF
$9.5M position · as of 2026-07-31
4.1%
LDR HIGH INCOME REALTY FUND
$1.1M position · as of 2026-06-30
3.5%
ALPS Active REIT ETF
$1.7M position · as of 2026-05-31
3.2%
Virtus Duff & Phelps Real Estate Securities Series
$3.2M position · as of 2026-06-30
2.7%
Virtus Duff & Phelps Real Estate Securities Fund
$9.5M position · as of 2026-06-30
2.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.6M
$12.7M
$2.8M
n/a
n/a
2024
$8.5M
$14.3M
$3.6M
n/a
n/a
2023
$8.2M
$12.2M
$3.3M
n/a
n/a
2022
$6.7M
$7.3M
$2.4M
n/a
n/a
2021
$6.1M
$1.1M
$1.7M
n/a
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. This filer reported no return figures.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $4.2M sold by insiders over 180 days, 232 funds added last quarter, $4.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
SBRA financials
Revenue growth
+25.4%
XBRL, annual
Net margin
43.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$859.6M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SBRA
| FY Dec 2025 | $774.6M |
| FY Dec 2024 | $703.2M |
| FY Dec 2023 | $647.5M |
| FY Dec 2022 | $624.8M |
| FY Dec 2021 | $569.5M |
| Jun 2026 | $235.9M |
| Mar 2026 | $221.8M |
| Dec 2025 | $211.9M |
| Sep 2025 | $190.0M |
| Jun 2025 | $189.2M |
| Mar 2025 | $183.5M |
| Dec 2024 | $182.3M |
| Sep 2024 | $178.0M |
At each fiscal year end
Single quarter
Net margin, TTM
+7.6%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SBRA
| FY Dec 2025 | +20.1% |
| FY Dec 2024 | +18.0% |
| FY Dec 2023 | +2.1% |
| FY Dec 2022 | -12.4% |
| FY Dec 2021 | -19.9% |
| Jun 2026 | -10.7% |
| Mar 2026 | +18.4% |
| Dec 2025 | +12.8% |
| Sep 2025 | +11.9% |
| Jun 2025 | +34.7% |
| Mar 2025 | +22.0% |
| Dec 2024 | +25.6% |
| Sep 2024 | +16.7% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM SBRA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.95x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity SBRA
| FY Dec 2025 | 0.90x |
| FY Dec 2024 | 0.88x |
| FY Dec 2023 | 0.86x |
| FY Dec 2022 | 0.82x |
| FY Dec 2021 | 0.71x |
| Jun 2026 | 0.95x |
| Mar 2026 | 0.96x |
| Dec 2025 | 0.90x |
| Sep 2025 | 0.92x |
| Jun 2025 | 0.91x |
| Mar 2025 | 0.89x |
| Dec 2024 | 0.88x |
| Sep 2024 | 0.90x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.14x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt SBRA
| FY Dec 2025 | 0.14x |
| FY Dec 2024 | 0.13x |
| FY Dec 2023 | 0.12x |
| FY Dec 2022 | 0.13x |
| FY Dec 2021 | 0.15x |
| Jun 2026 | 0.14x |
| Mar 2026 | 0.14x |
| Dec 2025 | 0.14x |
| Sep 2025 | 0.13x |
| Jun 2025 | 0.14x |
| Mar 2025 | 0.14x |
| Dec 2024 | 0.13x |
| Sep 2024 | 0.13x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+2.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SBRA
| FY Dec 2025 | +5.6% |
| FY Dec 2024 | +4.6% |
| FY Dec 2023 | +0.5% |
| FY Dec 2022 | -2.4% |
| FY Dec 2021 | -3.3% |
| Jun 2026 | +2.4% |
| Mar 2026 | +5.7% |
| Dec 2025 | +5.6% |
| Sep 2025 | +6.3% |
| Jun 2025 | +6.7% |
| Mar 2025 | +5.1% |
| Dec 2024 | +4.6% |
| Sep 2024 | +3.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SBRA
| FY Dec 2025 | +2.9% |
| FY Dec 2024 | +2.4% |
| FY Dec 2023 | +0.2% |
| FY Dec 2022 | -1.3% |
| FY Dec 2021 | -1.9% |
| Jun 2026 | +1.2% |
| Mar 2026 | +2.9% |
| Dec 2025 | +2.9% |
| Sep 2025 | +3.2% |
| Jun 2025 | +3.4% |
| Mar 2025 | +2.7% |
| Dec 2024 | +2.4% |
| Sep 2024 | +1.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital SBRA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed SBRA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
76.08x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing SBRA
| FY Dec 2025 | 29.59x |
| FY Dec 2024 | 32.07x |
| FY Dec 2023 | 285.40x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 75.04x |
| Mar 2026 | 30.52x |
| Dec 2025 | 29.59x |
| Sep 2025 | 25.53x |
| Jun 2025 | 23.95x |
| Mar 2025 | 29.12x |
| Dec 2024 | 32.07x |
| Sep 2024 | 45.39x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$7.4B
market value at close 2026-10-26 on 2026-07-27 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value SBRA
| FY Dec 2025 | $7.2B |
| FY Dec 2024 | $6.5B |
| FY Dec 2023 | $5.7B |
| FY Dec 2022 | $5.3B |
| FY Dec 2021 | $5.4B |
| Jun 2026 | $7.3B |
| Mar 2026 | $7.4B |
| Dec 2025 | $7.2B |
| Sep 2025 | $6.9B |
| Jun 2025 | $6.8B |
| Mar 2025 | $6.5B |
| Dec 2024 | $6.5B |
| Sep 2024 | $6.8B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield SBRA
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -66%, PEG needs growth
PEG, trailing SBRA
| FY Dec 2025 | 1.60x |
| FY Dec 2024 | 0.03x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | 6.10x |
| Dec 2025 | 1.60x |
| Sep 2025 | 0.33x |
| Jun 2025 | 0.09x |
| Mar 2025 | 0.15x |
| Dec 2024 | 0.03x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $774.6M | $703.2M | $647.5M | $624.8M |
| Net income | $155.6M | $126.7M | $13.8M | -$77.6M |
| EPS (diluted) | 0.64 | 0.54 | 0.06 | -0.34 |
| Operating cash flow | $348.6M | $310.5M | $300.6M | $315.7M |
| Cash | $71.5M | $60.5M | $41.3M | $49.3M |
| Long-term debt | $2.5B | $2.4B | $2.4B | $2.5B |
| Dividends paid | $289.5M | $280.1M | $277.4M | $277.2M |
SEC XBRL, fiscal years, as known on 2026-10-28
SBRA Stock Sonar score 6/7 axes
Find similar shapesCompareSBRA ranks highest on growth (86th percentile) and institutional and government (78th), and lowest on insider conviction (1st), among Real Estate peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SBRA filings, in plain words
Are Sabra Health Care REIT insiders buying or selling SBRA?
In the 180 days to 2026-10-28, Sabra Health Care REIT insiders were net sellers, a net $4.2M across purchases and sales reported on Form 4, by 1 seller.
Are there planned insider sales of SBRA?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $4.2M of stock; the latest, by Richard K. Matros, was filed 2026-09-08.
Read the full summary
In the 180 days to 2026-10-28, Sabra Health Care REIT insiders were net sellers of SBRA, a net $4.2M across purchases and sales reported on Form 4 by 1 seller. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $4.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
